SCHEMBL29855908

SCHEMBL29855908

CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 1/20 0.68
▸ C5AR1 P21730 1/20 0.64
▸ F2 P00734 4/20 0.60
▸ NMUR2 Q9GZQ4 4/20 0.58
▸ NMUR1 Q9HB89 4/20 0.58
▸ NPY2R P49146 5/20 0.58
▸ NPY4R P50391 5/20 0.58
▸ NPY5R Q15761 5/20 0.58
▸ NPY1R P25929 4/20 0.58
▸ CXCR4 P61073 1/20 0.57
▸ TFPI P10646 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30432142 0.94 MC4R (0.73) MC4RC5AR1F2NMUR2NMUR1
SCHEMBL31678903 0.91 MC4R (0.67) MC4RC5AR1F2NMUR2NMUR1
SCHEMBL29593954 0.89 C5AR1 (0.69) MC4RC5AR1F2NPY2RNPY4R
SCHEMBL29593655 0.89 C5AR1 (0.69) MC4RC5AR1F2NPY2RNPY4R
SCHEMBL29593115 0.89 C5AR1 (0.69) MC4RC5AR1F2NPY2RNPY4R
SCHEMBL30432646 0.89 CALCR (0.67) C5AR1F2NPY2RNPY4RNPY5R
SCHEMBL30607369 0.89 CALCR (0.62) MC4RC5AR1F2NPY2RNPY4R
SCHEMBL30176412 0.89 MC4R (0.63) MC4RF2NMUR2NMUR1NPY2R
SCHEMBL29641118 0.89 C5AR1 (0.60) MC4RC5AR1F2
SCHEMBL29880330 0.88 C5AR1 (0.64) MC4RC5AR1NPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136555-A9 IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) 2022-09-22 — — WO disclosed
Send feedback